event-banner-71-AACC-2019

Exhibition:

71st AACC Annual Scientific Meeting & Clinical Lab Expo

Anaheim, California

Exhibition dates:

August 6-8, 2019

Venue:

Anaheim Convention Center
800 West Katella Avenue
Anaheim, CA 92802
(714) 765-8950

Booth Number: 2952

Stanbio
an EKF Diagnostics Company

Website:

71st AACC Annual Scientific Meeting
& Clinical Lab Expo

At the 71st AACC Annual Scientific Meeting & Clinical Lab Expo, you’ll have the opportunity to:

  • Connect with global leaders in clinical chemistry, molecular diagnostics, mass spectrometry, translational medicine, lab management, and other areas of breaking science in laboratory medicine.
  • Learn about cutting edge technology. The AACC Clinical Lab Expo has more than 200 new product introductions each year.
  • Hear vital research and learn about important changes in the field. With nearly 300 educational opportunities in the form of lectures, plenary sessions, scientific sessions, and roundtable sessions, you can design an educational experience that meets your need to stay ahead of changes in the field.

Mr. Takuji Kohzuma

Takuji KohzumaMr Takuji Kohzuma Ph.D. Senior Manager, IVD Kit Product Group from Asahi Kasei Pharma is the inventor of the enzymatic method for Glycated Albumin and will be on our booth at AACC.

Mr Kohzuma has worked for Asahi Kasei Corp. since 1989. His career is full of achievements, several scientific reports and patents:

Company

1989 Asahi Kasei Corp.

2005 Asahi Kasei Pharma Corp.

Academic background

1987 Bachelor of Science: Kyushu University (Japan)

1989 Master of Science: Kyushu University (Japan)

2006 Doctor of Pharmacology:  Kyushu University (Japan)

Career

2002 Published first report of the “Enzymatic method for Glycated Albumin” (Clin Chim Acta)

2002 A member of a “Glycated Albumin Standardization Project”, of Committee on Diabetes Mellitus indices, Japan Society of Clinical Chemistry

2005 “Prize of technology” from Japan Society of Clinical Chemistry

2008 Reported the “JSCC Recommended Method for Glycated Albumin Measurement in Serum” as one of authors of Committee” on Journal of “Rinsho Kagaku”

2014 Adviser for a “Glycated Albumin Standardization Project”, of Committee on Diabetes Mellitus indices, Japan Society of Clinical Chemistry

2015 Reported the “Reference measurement Procedure and reference materials for GA determination (Annals Clin. Biochem.)

Others(July 2019)

Scientific reports:  29, including “Diabetologia”, “Atherosclerosis”, “Clinica Chimica Acta”, etc.

Patents: 55 including 6 of international patents, ”Composition for assaying glycated protein”

EKF’ Staff Attending:

Mike Salter – President, EKF Americas
Jami Meeks – VP Strategic Business Development
Trevor McCarthy –  Global Business Development Manager, Central Laboratory
Shane O’Neill – Global Director Scientific Affairs
Bart Battles – Sales Director/U.S. & Canada/Acute Care, Alternate Care, & Public Health
Brian Griffin – Sales Director/U.S. & Canada/Blood Banks & Plasma
Sergio Stilman – Sales Director/Latin America
Allan Leest – Regional Sales Manager/Latin America
Gino Rampolla – Regional Sales Manager/U.S. Southeast
Ed Balmelli – Regional Sales Manager/U.S. West